Entrada Therapeutics TRDA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 5.80 | 108.21 | -1.06 | -47,051 | -44 | |
| 2025Q2 | 6.72 | 109.14 | 10.29 | -1.05 | -46,849 | -43 |
| 2025Q1 | 9.04 | 125.60 | 5.18 | -0.42 | -21,790 | -17 |
| 2024Q4 | 17.29 | 793.91 | 11.77 | -0.04 | -5,867 | 1 |
| 2024Q3 | 15.98 | 136.28 | 5.69 | -0.51 | -21,658 | -14 |
| 2024Q2 | 14.25 | 92.44 | 20.48 | 1.55 | 53,423 | 55 |
| 2024Q1 | 14.17 | 83.36 | 0.68 | 21,113 | 23 | |
| 2023Q4 | 15.09 | 53.33 | -0.28 | 4,905 | -10 | |
| 2023Q3 | 15.80 | 77.57 | 1.07 | 14,012 | 35 | |
| 2023Q2 | 15.14 | 134.91 | -0.78 | -16,299 | -26 | |
| 2023Q1 | 14.50 | 185.08 | -0.21 | -5,780 | -7 | |
| 2022Q4 | 13.52 | -0.78 | -25,579 | -25 | ||
| 2022Q3 | 15.76 | -0.81 | -25,936 | -25 | ||
| 2022Q2 | 12.18 | 101.74 | -0.74 | -23,582 | -23 | |
| 2022Q1 | 9.39 | 102.21 | -0.69 | -22,151 | -22 | |
| 2021Q4 | 17.12 | 16.02 | -18,460 | -18 | ||
| 2021Q3 | -10.02 | -14,364 | -14 | |||
| 2021Q2 | -9,910 | -10 | ||||
| 2021Q1 | -0.41 | -8,393 | -8 | |||
| 2020Q4 | -8,653 | -9 |